# Octapharma Plasma Inc – FDA Inspection, Aug 29, 2024

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/02cffa56-07c0-46df-9718-1a7f7ca48c58
Source feed: FDA_Inspections

> FDA inspection 1250909 of Octapharma Plasma Inc, August 29, 2024. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1250909
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2024-08-29
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1329120 - 2026-07-23
- FDA Inspection 1317018 - 2026-04-22
- FDA Inspection 1312082 - 2026-03-30
- FDA Inspection 1310204 - 2026-03-19
- FDA Inspection 1282432 - 2026-03-11

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/kish-bolden/e24957d4-927f-40c7-a7ca-860fedce2e3f)
- [Issuing Officer](https://www.keypedia.com/people/steen-n-graham/e0ce4c37-b1f1-4d94-8071-2d89b74975fd)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/620b62aa-2a97-4307-a10b-c2402da97705

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d